See also this year's filing and all EDGAR filings for this company.
PDF Report 0001505497_2021_Biorestorative_Therapies_Inc.pdf
Logs
| warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
| warning | No stock price available | subcommand.plot | {} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('EntityCommonStockSharesOutstanding')"} |
Graph
Absolute values for 0001505497, Biorestorative Therapies Inc
| xvar | xval | |
|---|---|---|
| 0 | IntangibleAssets | 664,268 |
| 1 | AssetsNonCurrent | 473,849 |
| 2 | AssetsCurrent | 3,187,017 |
| 3 | PropertyPlantAndEquipment | 21,914 |
| 4 | remainder_Assets | 0 |
| 5 | LongTermLiabilities | 4,633,752 |
| 6 | LiabilitiesCurrent | 1,044,788 |
| 7 | remainder_Liabilities | 0 |
| 8 | LaborExpense | 0 |
| 9 | CostOfGoodsAndServicesSold | 0 |
| 10 | GeneralAndAdministrativeExpense | 1,786,716 |
| 11 | GoodwillImpairmentLoss | 0 |
| 12 | OperatingCostsAndExpenses | 0 |
| 13 | DepreciationDepletionAndAmortization | 0 |
| 14 | SellingAndMarketingExpense | 28,281 |
| 15 | ResearchAndDevelopmentExpense | 876,829 |
| 16 | remainder_Expenses | 137,250 |
| 17 | remainder_Revenues | 77,000 |
| 18 | remainder_NetIncome | -8,520,611 |
| 19 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 4,347,048 |
| 1 | Liabilities | 5,678,540 |
| 2 | Expenses | 2,829,076 |
| 3 | Revenues | 77,000 |
| 4 | StockholdersEquity | -1,331,492 |
| 5 | NetIncome | -11,272,687 |
| 6 | ComprehensiveNetIncome | -11,272,687 |
| 7 | BaseVar | 10,726,138 |
| 8 | EconomicCapitalRatio | -2.99 |
Edgar->Model Mapping
Feature Distribution
Change over Time
